ABCD1 p.Val123Ile
[switch to full view]Comments [show]
None has been submitted yet.
PMID: 26522770
[PubMed]
Kelly JT et al: "Potent antiviral agents fail to elicit genetically-stable resistance mutations in either enterovirus 71 or Coxsackievirus A16."
No.
Sentence
Comment
26
Sequencing revealed three different VP1 mutants in EV71 (I113L, I113M, I113M/V123I) and one in CVA16 (L113F) (Table 1).
X
ABCD1 p.Val123Ile 26522770:26:77
status: NEW27 Virus passaged in a combination of NLD/ GPP3 over 30 passages maintained the I113M/V123I mutations (n &#bc; 1).
X
ABCD1 p.Val123Ile 26522770:27:83
status: NEW30 Mutations I113M and V123I are located on the inside of the VP1 pocket and I113 is one of the residues involved in compound binding (Fig. 2B).
X
ABCD1 p.Val123Ile 26522770:30:20
status: NEW35 The difference in the lowest free energy of folding (DDGfolding) between the WT and EV71 I113M or V123I mutants was &#fe;0.73 and &#fe; 0.98 kcal/mol, respectively.
X
ABCD1 p.Val123Ile 26522770:35:98
status: NEW37 The mutations I113M and V123I appeared to cause a shrinking of the VP1 pocket, with the methionine residue pointing inside, suggesting a steric clash with the Fig. 1.
X
ABCD1 p.Val123Ile 26522770:37:24
status: NEW52 Virus/Compound Mutation(s) Number sequenced EV71/NLD I113M (62%), I113L (31%), I113M/V123I (7%) n &#bc; 13 EV71/GPP3 I113M/V123I n &#bc; 4 EV71/ALD I113M/V123I n &#bc; 1 EV71/NLD &#fe; GPP3 I113M/V123I n &#bc; 12 CVA16/GPP3 L113F n &#bc; 10 Fig. 2.
X
ABCD1 p.Val123Ile 26522770:52:85
status: NEWX
ABCD1 p.Val123Ile 26522770:52:123
status: NEWX
ABCD1 p.Val123Ile 26522770:52:154
status: NEWX
ABCD1 p.Val123Ile 26522770:52:196
status: NEW62 The two mutated side chains I113M and V123I are shown as grey balls-and-sticks.
X
ABCD1 p.Val123Ile 26522770:62:38
status: NEW73 These data suggest that the I113M/V123I mutation prevented compound binding as the thermostability of the resistant isolates was not increased in the presence of NLD.
X
ABCD1 p.Val123Ile 26522770:73:34
status: NEW74 The bulkier side chains of the I113M and L113F mutations are predicted to point directly into the pocket, reducing the space available for inhibitor binding and the V123I mutation reduces this further.
X
ABCD1 p.Val123Ile 26522770:74:165
status: NEW